Herpes Simplex Virus Treatment Market: Antiviral Drugs Lead as Vaccines Emerge as Fastest-Growing Segment
The [Herpes Simplex Virus Treatment Market] is experiencing steady growth, driven by the high global prevalence of HSV infections and the increasing demand for effective therapies. Valued at approximately USD 1.48 billion in 2024, the market is projected to reach USD 2.19 billion by 2035, growing at a compound annual growth rate (CAGR) of 3.62%, according to Market Research Future ....
0 Comments 0 Shares 4 Views 0 Reviews